RAPT Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -200 | |||
EBITDA | -17,443 | -19,013 | -54,178 | -19,491 |
EBIT | -17,643 | -19,265 | -54,465 | -19,788 |
Net Income | -17,643 | -17,165 | -53,249 | -18,432 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -11,311 | -52,457 | -10,438 | -17,639 |
Cash | 41,886 | 60,257 | 169,735 | 37,900 |
Basic Shares | 26,949 | 215,410 | 46,688 | 38,903 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $1,527 | $3,813 |
Gross Profit | -3,551 | 1,527 | 3,813 | |
EBITDA | -126,326 | -125,846 | -84,748 | -68,213 |
EBIT | -129,865 | -127,062 | -85,795 | -69,209 |
Net Income | -129,865 | -116,798 | -81,881 | -68,208 |
Net Change In Cash | 0 | 0 | 1,527 | 3,813 |
Cost of Revenue | 14,919 | -891 | ||
Free Cash Flow | -83,419 | -98,173 | -71,616 | -61,781 |
Cash | 169,735 | 47,478 | 38,946 | 24,027 |
Basic Shares | 40,761 | 38,338 | 32,540 | 27,390 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.65 |
2025-03-31 | -$0.08 |
2024-12-31 | -$1.22 |
2024-09-30 | -$0.47 |
